Economic costs of diabetes in the U.S. in 2012 - PubMed (original) (raw)

. 2013 Apr;36(4):1033-46.

doi: 10.2337/dc12-2625. Epub 2013 Mar 6.

Collaborators, Affiliations

Economic costs of diabetes in the U.S. in 2012

American Diabetes Association. Diabetes Care. 2013 Apr.

Abstract

Objective: This study updates previous estimates of the economic burden of diagnosed diabetes and quantifies the increased health resource use and lost productivity associated with diabetes in 2012.

Research design and methods: The study uses a prevalence-based approach that combines the demographics of the U.S. population in 2012 with diabetes prevalence, epidemiological data, health care cost, and economic data into a Cost of Diabetes Model. Health resource use and associated medical costs are analyzed by age, sex, race/ethnicity, insurance coverage, medical condition, and health service category. Data sources include national surveys, Medicare standard analytical files, and one of the largest claims databases for the commercially insured population in the U.S.

Results: The total estimated cost of diagnosed diabetes in 2012 is 245billion,including245 billion, including 245billion,including176 billion in direct medical costs and 69billioninreducedproductivity.Thelargestcomponentsofmedicalexpendituresarehospitalinpatientcare(4369 billion in reduced productivity. The largest components of medical expenditures are hospital inpatient care (43% of the total medical cost), prescription medications to treat the complications of diabetes (18%), antidiabetic agents and diabetes supplies (12%), physician office visits (9%), and nursing/residential facility stays (8%). People with diagnosed diabetes incur average medical expenditures of about 69billioninreducedproductivity.Thelargestcomponentsofmedicalexpendituresarehospitalinpatientcare(4313,700 per year, of which about 7,900isattributedtodiabetes.Peoplewithdiagnoseddiabetes,onaverage,havemedicalexpendituresapproximately2.3timeshigherthanwhatexpenditureswouldbeintheabsenceofdiabetes.Forthecostcategoriesanalyzed,careforpeoplewithdiagnoseddiabetesaccountsformorethan1in5healthcaredollarsintheU.S.,andmorethanhalfofthatexpenditureisdirectlyattributabletodiabetes.Indirectcostsincludeincreasedabsenteeism(7,900 is attributed to diabetes. People with diagnosed diabetes, on average, have medical expenditures approximately 2.3 times higher than what expenditures would be in the absence of diabetes. For the cost categories analyzed, care for people with diagnosed diabetes accounts for more than 1 in 5 health care dollars in the U.S., and more than half of that expenditure is directly attributable to diabetes. Indirect costs include increased absenteeism (7,900isattributedtodiabetes.Peoplewithdiagnoseddiabetes,onaverage,havemedicalexpendituresapproximately2.3timeshigherthanwhatexpenditureswouldbeintheabsenceofdiabetes.Forthecostcategoriesanalyzed,careforpeoplewithdiagnoseddiabetesaccountsformorethan1in5healthcaredollarsintheU.S.,andmorethanhalfofthatexpenditureisdirectlyattributabletodiabetes.Indirectcostsincludeincreasedabsenteeism(5 billion) and reduced productivity while at work ($20.8 billion) for the employed population, reduced productivity for those not in the labor force ($2.7 billion), inability to work as a result of disease-related disability ($21.6 billion), and lost productive capacity due to early mortality ($18.5 billion).

Conclusions: The estimated total economic cost of diagnosed diabetes in 2012 is 245billion,a41245 billion, a 41% increase from our previous estimate of 245billion,a41174 billion (in 2007 dollars). This estimate highlights the substantial burden that diabetes imposes on society. Additional components of societal burden omitted from our study include intangibles from pain and suffering, resources from care provided by nonpaid caregivers, and the burden associated with undiagnosed diabetes.

PubMed Disclaimer

Figures

Figure 1

Figure 1

Percent of medical condition–specific expenditures associated with diabetes. Data sources: NIS (2010), NAMCS (2008–2010), NHAMCS (2007–2009), and MEPS (2006–2010 or 2008–2010). Note: See

Supplementary Table 2

for diagnosis codes for each category of medical condition.

Figure 2

Figure 2

Net present value of future lost earnings from premature death. Data sources: analysis of the NHIS (2009–2011), CPS (2011), and CDC mortality data.

Comment in

Similar articles

Cited by

References

    1. American Diabetes Association Economic costs of diabetes in the U.S. in 2002. Diabetes Care 2003;26:917–932 - PubMed
    1. American Diabetes Association Economic costs of diabetes in the U.S. in 2007. Diabetes Care 2008;31:596–615 - PubMed
    1. Boyle JP, Thompson TJ, Gregg EW, Barker LE, Williamson DF. Projection of the year 2050 burden of diabetes in the US adult population: dynamic modeling of incidence, mortality, and prediabetes prevalence. Popul Health Metr 2010;8:29. - PMC - PubMed
    1. U.S. Census Bureau. Population Projections: 2008. National Population Projections [Internet], 2008. Available from http://www.census.gov/population/projections/data/national/2008.html Accessed 16 January 2013
    1. U.S. Bureau of Labor Statistics. Consumer Price Index: CPI Databases [Internet]. Available from http://www.bls.gov/cpi/data.htm. Accessed 16 January 2013

MeSH terms

LinkOut - more resources